Premium
Nebulized corticosteroid improves pulmonary function and outcome in experimental porcine septicemia
Author(s) -
Walther S.,
Jansson I.,
Gunnarsson M.,
Lennquist S.
Publication year - 1991
Publication title -
acta anaesthesiologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.738
H-Index - 107
eISSN - 1399-6576
pISSN - 0001-5172
DOI - 10.1111/j.1399-6576.1991.tb03363.x
Subject(s) - medicine , corticosteroid , pulmonary function testing , intensive care medicine , outcome (game theory) , anesthesia , surgery , mathematics , mathematical economics
Nebulized beclomethasone dipropionate was administered to six anesthetized and artificially ventilated pigs at 6‐hourly intervals after infusion of live S. aureus ( aerosol group ). Changes in pulmonary mechanics, gas exchange and hemodynamics during an observation period of 44 h were compared with those in six pigs subjected to the same insults but given no corticosteroid ( non‐treatment group ). Six pigs served as controls, without sepsis or aerosol, but with the same general management ( control group ). The septic insult induced an acute 3‐fold increase in mean pulmonary artery pressure (MPAP) in the aerosol and non‐treatment group. MPAP fell to near baseline levels in the aerosol group, but remained significantly higher in the non‐treatment group. Mean systemic arterial pressure fell more in the non‐treatment than in the aerosol group, reaching its lowest level at 32 h. Pulmonary function was less affected in the aerosol group, with significantly better maintenance of arterial oxygenation, lower venous admixture and superior lung‐thorax compliance than in the non‐treatment group. Survival was significantly improved in the aerosol group. In this porcine model of septicemia‐induced adult respiratory distress syndrome, nebulized corticosteroid thus attenuated the development of respiratory failure.